Skip to content

Opening book details…

About this Medicine article

461 POSTER Early phase experience with pralatrexate (10-propargy l-10-deazaaminopterin [PRX]), a novel antifolate with high afnity forthe reduced folate carrier, in patients with chemotherapy refractory lymphoproliferative malignancies by O. O'Connor; E. Hamlin; E. Neylon; C. Moskowitz; C. Portlock; A. Noy; F. Sirotnak; A. Zelenetz; D. Mould; S. Horwitz is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
O. O'Connor; E. Hamlin; E. Neylon; C. Moskowitz; C. Portlock; A. Noy; F. Sirotnak; A. Zelenetz; D. Mould; S. Horwitz
Publisher
Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 1359-6349)
Published
2006
Field
Medicine (Health Sciences)

More by O. O'Connor; E. Hamlin; E. Neylon; C. Moskowitz; C. Portlock; A. Noy; F. Sirotnak; A. Zelenetz; D. Mould; S. Horwitz

Browse all works by O. O'Connor; E. Hamlin; E. Neylon; C. Moskowitz; C. Portlock; A. Noy; F. Sirotnak; A. Zelenetz; D. Mould; S. Horwitz